Lemaitre Vascular Inc

Research Lemaitre Vascular Inc (LMAT) on Bullrun: valuation model: 11.7% undervalued, market cap USD 1.81B, P/E 28.1, dividend yield 1.2%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerLMAT
ExchangeNASDAQ
CountryUnited States
SectorHealthcare
IndustryMedical Instruments & Supplies
CurrencyUSD
Valuation signal11.7% undervalued
Market capUSD 1.81B
P/E28.1
Dividend yield1.2%
Financial periodQ2 2026
RevenueUSD 70.38M
Net incomeUSD 17.05M
Free cash flowUSD 13.65M
Gross margin72.1%

Valuation Snapshot

Bullrun's latest valuation model marks Lemaitre Vascular Inc as 11.7% undervalued; latest market cap is USD 1.81B; P/E is 28.1; dividend yield is 1.2%.

Peer valuation comparison

Latest P/E is 28.13x versus a Healthcare sector median of 24.46x (15.0% above).

Latest dividend yield is 1.19% versus a Healthcare sector median of 2.11% (43.6% below).

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	USD 249.60M	USD 57.70M	USD 74.47M	71.5%	2.52	USD 28.24M	USD 185.59M	USD 393.52M
FY2024	USD 219.86M	USD 44.00M	USD 37.16M	68.6%	1.93	USD 25.61M	USD 185.69M	USD 337.29M
FY2023	USD 193.48M	USD 30.10M	USD 29.49M	65.7%	1.34	USD 24.27M	USD 19.10M	USD 297.90M
FY2022	USD 161.65M	USD 20.60M	USD 22.15M	64.9%	0.93	USD 19.13M	USD 17.21M	USD 268.20M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-25	USD 1.81B	28.1	1.2%	0.95
2025	2025-12-31	USD 1.85B	32.3	1.0%	0.8
2024	2024-12-31	USD 2.08B	47.7	0.7%	0.64
2023	2023-12-29	USD 1.26B	46.5	1.0%	0.56
2022	2022-12-30	USD 1.01B	47.9	1.1%	0.52
2021	2021-12-31	USD 1.10B	39.9	0.9%	0.44

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.95 USD, yield 1.2%.

Year	Dividends/share
FY2025	0.8 USD
FY2024	0.64 USD
FY2023	0.56 USD
FY2022	0.5 USD

About Lemaitre Vascular Inc

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system;

Related stock research

United States stocks United States Healthcare stocks A-Z stock index

Other Healthcare stocks

Align Technology Inc (ALGN) Angiodynamic Inc (ANGO) Aptargroup Inc (ATR) Atricure Inc (ATRC) Avantor Inc (AVTR) Azenta Inc (AZTA) Baxter International Inc (BAX) Becton Dickinson & Company (BDX) Biolife Solutions Inc (BLFS) Bionano Genomics Inc (BNGO) Cooper Companies Inc (COO) Daxor Corp (DXR)

Frequently asked questions

Is Lemaitre Vascular Inc overvalued or undervalued?

Bullrun's valuation model currently marks Lemaitre Vascular Inc as 11.7% undervalued.

What is Lemaitre Vascular Inc's market cap?

Lemaitre Vascular Inc's market capitalization is USD 1.81B.

What is Lemaitre Vascular Inc's P/E ratio?

Lemaitre Vascular Inc's price-to-earnings (P/E) ratio is 28.1.

Does Lemaitre Vascular Inc pay a dividend?

Lemaitre Vascular Inc has a dividend yield of 1.2%.

What does Lemaitre Vascular Inc do?

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific.